^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
trastuzumab pamirtecan (BNT323)
i
Other names: BNT323, DB-1303, BNT 323, DB1303, DB 1303, BNT-323
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
BioNTech, DualityBio
Drug class:
Topoisomerase I inhibitor, HER2-targeted antibody-drug conjugate
Related drugs:
